Mostrar el registro sencillo del ítem
| dc.contributor.author | Miguel, Carolina | |
| dc.contributor.author | Cirera, Alejandra | |
| dc.date.accessioned | 2025-12-03T11:16:05Z | |
| dc.date.available | 2025-12-03T11:16:05Z | |
| dc.date.issued | 2021-11 | |
| dc.identifier.citation | Miguel C, Cirera A. Retrospective study of the clinical effect of incobotulinumtoxinA for the management of myofascial pain syndrome in refractory patients. Toxicon. noviembre de 2021;203:117-20. | |
| dc.identifier.issn | 0041-0101 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/23043 | |
| dc.description.abstract | The aim was to evaluate the effectiveness and safety of IncobotulinumtoxinA (IncoA) for the management of myofascial pain syndrome (MPS) in refractory patients. This single-center, observational, retrospective study includes 37 patients. The pain reduction was 4.7 points (95%CI: 5.6 to -3.8) from baseline to one-month post-injection (using a 10-point visual analogue scale). Only 18.9% experienced mild adverse events. In conclusion, IncoA is an effective and safe alternative for the treatment of MPS in refractory patients. | |
| dc.language.iso | eng | |
| dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | |
| dc.rights | Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0 | * |
| dc.subject.mesh | Botulinum Toxins, Type A/therapeutic use | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Myofascial Pain Syndromes/drug therapy | |
| dc.subject.mesh | Pain Measurement | |
| dc.subject.mesh | Retrospective Studies | |
| dc.subject.mesh | Treatment Outcome | |
| dc.title | Retrospective study of the clinical effect of incobotulinumtoxinA for the management of myofascial pain syndrome in refractory patients | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 34600908 | |
| dc.relation.publisherversion | https://linkinghub.elsevier.com/retrieve/pii/S0041010121002725 | |
| dc.identifier.doi | 10.1016/j.toxicon.2021.09.022 | |
| dc.journal.title | Toxicon | |
| dc.identifier.essn | 1879-3150 |